- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 211/96 - Atome de soufre
Détention brevets de la classe C07D 211/96
Brevets de cette classe: 372
Historique des publications depuis 10 ans
|
23
|
23
|
27
|
23
|
24
|
19
|
28
|
17
|
30
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19989 |
13 |
| F. Hoffmann-La Roche AG | 7945 |
9 |
| Helsinn Healthcare SA | 229 |
8 |
| Bristol-myers Squibb Company | 4881 |
7 |
| FUJIFILM Corporation | 29458 |
7 |
| Takeda Pharmaceutical Company Limited | 2711 |
7 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 286 |
5 |
| Board of Regents, The University of Texas System | 5821 |
5 |
| Toray Industries, Inc. | 6950 |
5 |
| Arete Therapeutics, Inc. | 23 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 704 |
5 |
| Shionogi & Co., Ltd. | 852 |
5 |
| Novartis AG | 10741 |
4 |
| Boehringer Ingelheim International GmbH | 4641 |
4 |
| California Institute of Technology | 3984 |
4 |
| Abbvie Inc. | 1799 |
4 |
| Amicus Therapeutics, Inc. | 351 |
4 |
| Axikin Pharmaceuticals, Inc. | 14 |
4 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 950 |
4 |
| Incyte Corporation | 1026 |
4 |
| Autres propriétaires | 259 |